Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000322

Drug Information
SynonymsNCGC00016710-01; Clemastine [USAN:BAN]; Tavegyl; HS 592; 14976-57-9; Spectrum2_000689; Prestwick2_000306; AC1L1CAE; Clemastina; IDI1_000285; KBio1_000285; NINDS_000285; HMS2089I22; Spectrum3_000353; C21H26ClNO; Prestwick1_000306; (+)-(2R)-2-(2-(((R)-p-Chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine; (2R)-2-(2-{[(1R)-1-(4-chlorophenyl)-1-phenylethyl]oxy}ethyl)-1-methylpyrrolidine; CHEBI:3738; NCGC00015281-01; BSPBio_002045; clemastine; Clemastinum [INN-Latin]; Prestwick0_000306; Mecloprodin; (+)-(2R)-2-[2-[[(R)-p-Chloro-alpha-methyl-alpha-phenylbenzyl]oxy]ethyl]-1-methylpyrrolidine; Meclastine; DB00283; BSPBio_000272; SPBio_000817; (2R)-2-{2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl}-1-methylpyrrolidine; KBioGR_001570; 15686-51-8; Spectrum5_001520; BPBio1_000300; 2(R)-[2-[(1R)-(4-Chlorophenyl)-1-phenyl-ethoxy]ethyl-1-methylpyrrolidine; Clemastinum; Lopac-C-8903; Meclastin; HS-592; (2R)-2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine; CAS-14976-57-9; UNII-95QN29S1ID; CID26987; BRD-K30240666-051-05-0; AC1Q3N52; CLEMASTINE FUMARATE; BIDD:GT0391; SPBio_002491; CHEMBL1626; Clemastina [INN-Spanish]; Spectrum4_000955; LS-137531; DivK1c_000285; Tavist (*Fumarate*); Tocris-1453; Tavist; 2-(2-(4-Chlor-alpha-methylbenzhydryloxy)ethyl)-1-methylpyrrolidin; NCGC00025168-01; Prestwick3_000306; KBio3_001265    
Trade NameTavist; Tavegyl    
CompanyNorvatis Phamaceuticals Corporation    
IndicationAllergic rhinitisApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassAnti-Allergic Agents    
CAS NumberCAS 15686-51-8
PubChem Compound IDCID 26987.    
PubChem Substance IDSID 205033.    
SuperDrug ATC IDD04AA14;    
SuperDrug CAS ID015686518;    
TargetHistamine H1 receptorAntagonist[2][3]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 073283 To Reference
Ref 2Histamine upregulates keratinocyte MMP-9 production via the histamine H1 receptor. J Invest Dermatol. 2008 Dec;128(12):2783-91. Epub 2008 Jun 12. To Reference
Ref 3Stereoselective synthesis of (-)-hydroxyclemastine as a versatile intermediate for the H1 receptor antagonist clemastine. Arch Pharm Res. 2007 Dec;30(12):1521-5. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543